Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19.  

How can we help you? Learn More >

Thomas Chatzopoulos

Vice President, Global Pharmacovigilance

Prior to becoming VP of Global Pharmacovigilance at ProPharma Group, Thomas served as Senior Director, Drug Safety Center EAPA for PRA Health Sciences overseeing the PV services for multiple clients in Europe and Asia Pacific. Before joining PRA he was Director of Pharmacovigilance at PharmaLex implementing global PV services for multiple small to mid-size clients.

Thomas also worked more than 20 years within the pharmaceutical industry at several global positions within PV and Quality Assurance at Grünenthal, Novartis, and Boehringer Ingelheim. Between 2012 and 2018, as Global Head Partner Management at Boehringer Ingelheim, Thomas implemented and maintained the preferred service provider strategy within Global PV overseeing the service provided by more than 300 people.

Thomas earned his chemical intermediate examination (BSc) and Diploma in Biology (MSc) at the RWTH Aachen University.

Company Blog

April 1, 2020
COVID-19 Pandemic in the EU: Fraudulent Medicines, Test Kit Shortage,…
The COVID-19 pandemic is creating many new challenges for our industry around the world.… Read More
March 31, 2020
Ten Tips for Conducting Successful Virtual FDA Meetings in the…
Ten tips for Sponsors now facing virtual FDA meetings rather than face-to-face interactions, and how to… Read More
March 25, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting clinical trials across Europe? Hanneke Dominicus provides more information on… Read More
More Articles


All Events
Contact Us